Search Results - michael+vanwyngarden

1 Results Sort By:
Personalized medicine assay for multiple myeloma treatment
A team of University of Colorado researchers have developed a novel, personalized drug sensitivity assay to assess whether a patient’s myeloma tumor cells are resistant or sensitive to commonly used anti-myeloma drugs. Mononuclear cells recovered from a patient’s bone marrow biopsy are incubated with individual drugs or a drug cocktail....
Published: 11/30/2023   |   Inventor(s): Daniel Sherbenou, Michael VanWyngarden, Zachary Walker
Disease Areas Oncology
Category(s): Diagnostics
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum